BACK Imac (BACK) Insider Trading, Ownership & Congress Trades
Healthcare Services · Services-specialty outpatient facilities, nec · CIK 0001729944
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Imac insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for IMAC Holdings, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 8 earlier Form 4 trades (code P or S) here by this insider (1 buy, 7 sales), the last on Mar 27, 2024.
- The trade is 0.0% of the 141,230 shares held after it.
- No other insider bought within 30 days.
Insider activity: Insider Ruiz Jorge bought about $3 of BACK on Apr 5, 2024.Context
- 7 earlier Form 4 trades (code P or S) here by this insider (1 buy, 6 sales), the last on Mar 25, 2024.
- The trade is 3.5% of the 141,229 shares held after it.
- No other insider sold within 30 days.
Insider activity: Insider Ruiz Jorge sold about $15.0K of BACK on Mar 27, 2024.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (1 buy, 1 sale), the last on Mar 22, 2024.
- The trade is 0.1% of the 148,285 shares held after it.
- No other insider sold within 30 days.
Insider activity: Insider Ruiz Jorge sold about $242 of BACK on Mar 25, 2024.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (1 buy, 1 sale), the last on Mar 22, 2024.
- The trade is 0.1% of the 148,085 shares held after it.
- No other insider sold within 30 days.
Insider activity: Insider Ruiz Jorge sold about $488 of BACK on Mar 25, 2024.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (1 buy, 1 sale), the last on Mar 22, 2024.
- The trade is 0.3% of the 147,585 shares held after it.
- No other insider sold within 30 days.
Insider activity: Insider Ruiz Jorge sold about $1.2K of BACK on Mar 25, 2024.9 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
-99.6% year over year
below 99% of Healthcare Services
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
0.1% of the float short (float per yahoo 2026-10-26) · 1.4 days to cover · settled 2026-09-30
below 86% of Healthcare Services
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch BACK
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-99.2%12M
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns BACK: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in BACK
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
BACK planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
BACK financials
Revenue growth
-99.6%
XBRL, annual
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$22.7K
four quarters, 2024-10-01 to 2025-09-30
Revenue, TTM BACK
| FY Dec 2024 | n/a |
| FY Dec 2023 | $8.5M |
| FY Dec 2022 | $16.2M |
| FY Dec 2021 | $14.4M |
| FY Dec 2020 | $12.8M |
| Sep 2025 | $21.2K |
| Jun 2025 | $0 |
| Mar 2025 | $1.5K |
| Dec 2024 | $0 |
| Sep 2024 | $56.3K |
| Jun 2024 | $15.8K |
| Mar 2024 | n/a |
| Dec 2023 | n/a |
At each fiscal year end
Single quarter
Net margin, TTM
n/a
revenue under $1M, the ratio says nothing
Net margin, TTM BACK
| FY Dec 2024 | n/a |
| FY Dec 2023 | -111.1% |
| FY Dec 2022 | -113.1% |
| FY Dec 2021 | -73.3% |
| FY Dec 2020 | -43.2% |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
| Mar 2024 | n/a |
| Dec 2023 | n/a |
At each fiscal year end
Single quarter
Free cash flow, TTM
-$5.2M
operating cash flow minus capex, 2024-10-01 to 2025-09-30
Free cash flow, TTM BACK
| FY Dec 2024 | -$3.5M |
| FY Dec 2023 | -$3.1M |
| FY Dec 2022 | -$10.6M |
| FY Dec 2021 | -$8.3M |
| FY Dec 2020 | -$6.1M |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
| Mar 2024 | n/a |
| Dec 2023 | n/a |
At each fiscal year end
Single quarter
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Debt to equity BACK
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | 0.58x |
| FY Dec 2021 | 0.02x |
| FY Dec 2020 | 0.57x |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
| Mar 2024 | n/a |
| Dec 2023 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-1.61x
TTM operating cash flow over long-term 2023-09-30 (24 months older than the period end) plus current 2024-12-31 (9 months older than the period end)
Cash flow to debt BACK
| FY Dec 2024 | -1.04x |
| FY Dec 2023 | -0.92x |
| FY Dec 2022 | -3.79x |
| FY Dec 2021 | -21.13x |
| FY Dec 2020 | -1.34x |
| Sep 2025 | -1.61x |
| Jun 2025 | -1.50x |
| Mar 2025 | -1.31x |
| Dec 2024 | -1.04x |
| Sep 2024 | -0.61x |
| Jun 2024 | -0.67x |
| Mar 2024 | -0.52x |
| Dec 2023 | -0.92x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
average equity is zero or negative
Return on equity BACK
| FY Dec 2024 | n/a |
| FY Dec 2023 | -483.2% |
| FY Dec 2022 | -162.0% |
| FY Dec 2021 | -81.8% |
| FY Dec 2020 | -70.4% |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
| Mar 2024 | n/a |
| Dec 2023 | -483.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-1,401%
TTM net income over average of 2024-09-30 and 2025-09-30
Return on assets BACK
| FY Dec 2024 | -661.9% |
| FY Dec 2023 | -154.1% |
| FY Dec 2022 | -95.6% |
| FY Dec 2021 | -44.9% |
| FY Dec 2020 | -27.6% |
| Sep 2025 | -1,401% |
| Jun 2025 | -701.4% |
| Mar 2025 | -1,057% |
| Dec 2024 | -661.9% |
| Sep 2024 | -190.3% |
| Jun 2024 | -177.8% |
| Mar 2024 | -181.4% |
| Dec 2023 | -154.1% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on invested capital BACK
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| FY Dec 2020 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
| Mar 2024 | n/a |
| Dec 2023 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
capital employed is zero or negative
Return on capital employed BACK
| FY Dec 2024 | n/a |
| FY Dec 2023 | -327.1% |
| FY Dec 2022 | -87.9% |
| FY Dec 2021 | -56.0% |
| FY Dec 2020 | -46.4% |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
| Mar 2024 | -1,025% |
| Dec 2023 | -327.1% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing BACK
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| FY Dec 2020 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
| Mar 2024 | n/a |
| Dec 2023 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$2.2M
market value at close 2026-10-23 on 2025-12-16 shares, plus long-term 2023-09-30 (24 months older than the period end) plus current 2024-12-31 (9 months older than the period end), minus cash 2024-06-30
Enterprise value BACK
| FY Dec 2024 | $4.7M |
| FY Dec 2023 | $5.3M |
| FY Dec 2022 | $198.0M |
| FY Dec 2021 | $889.6M |
| FY Dec 2020 | $545.3M |
| Sep 2025 | $2.4M |
| Jun 2025 | $2.3M |
| Mar 2025 | $2.4M |
| Dec 2024 | $4.7M |
| Sep 2024 | $3.4M |
| Jun 2024 | $4.6M |
| Mar 2024 | $6.5M |
| Dec 2023 | $5.3M |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-276,379%
TTM free cash flow over market value at close 2026-10-23
FCF yield BACK
| FY Dec 2024 | -136.6% |
| FY Dec 2023 | -124.1% |
| FY Dec 2022 | -5.4% |
| FY Dec 2021 | -0.9% |
| FY Dec 2020 | -1.1% |
| Sep 2025 | -1,974% |
| Jun 2025 | -2,585% |
| Mar 2025 | -1,816% |
| Dec 2024 | -136.6% |
| Sep 2024 | -170.2% |
| Jun 2024 | -97.6% |
| Mar 2024 | -54.7% |
| Dec 2023 | -124.1% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing BACK
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| FY Dec 2020 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
| Mar 2024 | n/a |
| Dec 2023 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2024-12 | 2023-12 | 2022-12 | 2021-12 | |
|---|---|---|---|---|
| Revenue | $72.0K | n/a | $16.2M | $14.4M |
| Gross profit | -$233.2K | n/a | n/a | n/a |
| Operating income | -$5.6M | -$6.4M | -$11.8M | -$10.1M |
| Net income | -$9.0M | -$9.4M | -$18.3M | -$10.5M |
| EPS (diluted) | -7.76 | -8.47 | -19.43 | n/a |
| Operating cash flow | -$3.2M | -$2.8M | -$10.3M | -$7.6M |
| Cash | n/a | $221.5K | $763.2K | $7.1M |
| Long-term debt | n/a | n/a | $2.7M | $359.2K |
SEC XBRL, fiscal years, as known on 2026-10-27
BACK Stock Sonar score 3/7 axes
Find similar shapesCompareBACK ranks highest on risk and compliance (89th percentile) and financial health (18th), and lowest on growth (1st), among Healthcare Services peers.
3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
